Clinical Trials Browser

Phase 1/2 × sepantronium × Thoracic × Clear all

NCT01100931 2015-10-19

A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II)

Phase 1/2 Completed

42 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung